Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of ZG-002 tablets in moderate-to-severe plaque psoriasis
CTR20263697Phase 2Active
- Sponsor
- Zhigen Pharmaceutical
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZG-002 in plaque psoriasis, sponsored by Zhigen Pharmaceutical. Started Oct 2026; status: active.
02
Drugs
ZG-002
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20263697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263697.